BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)

John D Kelly, Wei Shen Tan, Nuria Porta, Hugh Mostafid, Robert Huddart, Andrew Protheroe, Richard Bogle, Jane Blazeby, Alison Palmer, Jo Cresswell, Mark Johnson, Richard Brough, Sanjeev Madaan, Stephen Andrews, Clare Cruickshank, Stephanie Burnett, Lauren Maynard, Emma Hall, BOXIT Investigators

Research output: Contribution to journal › Article (Academic Journal) › peer-review

25 Citations (Scopus)
481 Downloads (Pure)

Fingerprint

Dive into the research topics of 'BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology